Hartford Hospital

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Hartford Hospital sits in the top decile of US sponsors by registered trial count (#290 of 15,742 sponsors by registered trial count).

75 total trials 8 currently recruiting 56 completed top decile by trial count

Hartford Hospital: 75 sponsored US clinical trials, 8 recruiting.

Hartford Hospital sponsors 75 registered US clinical trials on ClinicalTrials.gov, 8 of them currently recruiting, and 56 completed. 15 of these trials are in Phase 3-4 (later-stage) and 17 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 3 trials.

Top-decile sponsor footprint

Hartford Hospital ranks in the top decile of sponsors by registered trial count (#290 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 69/100

56 of 61 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

75 total, page 1 of 2

RECRUITING NA

Motivating Increases in Physical Activity for Prevention of Weight Regain After Metabolic Bariatric Surgery

NCT06484621
RECRUITING NA

Improving Availability of Intranasal Naloxone

NCT05877118
RECRUITING NA

Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery

NCT06445413
RECRUITING Phase 4

Multifidus Cervicis Plane Block Vs. Sham Block For Posterior Cervical Spine Fusion Surgery

NCT05996133
RECRUITING Phase 4

Etomidate Versus Propofol in CABG Surgery

NCT06068764
RECRUITING NA

Target ADHD Executive Working Memory Replication Study

NCT06446284
RECRUITING Phase 4

Liposomal Bupivacaine/Bupivacaine in Rectus Sheath Blocks Versus Ropivacaine in Rectus Sheath Blocks And Catheters

NCT05972018
RECRUITING Phase 4

Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy

NCT05224089
ACTIVE NOT RECRUITING NA

Use of Artificial Intelligence by Urogynecologic Patients

NCT06481436
ACTIVE NOT RECRUITING Phase 1

THC Memory & Reward Learning Pilot

NCT05116527
ACTIVE NOT RECRUITING Phase 1

Hippocampal Response to Acute Oral Doses of CBD During an fMRI Memory Task

NCT04778644
ACTIVE NOT RECRUITING

Neuroimaging Predictors of Bariatric Surgical Outcome

NCT03582748
NOT YET RECRUITING NA

Testing a Brief Exercise Intervention in Hoarding Disorder

NCT06561659
NOT YET RECRUITING NA

DePuy Synthes Variable Angle LCP Patella Plating System Study

NCT05824676
TERMINATED Phase 4

Imipenem/Cilastatin/Relebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic Fibrosis

NCT05561764
COMPLETED NA

A Feasibility Open Trial of App-Enhanced Brief CBT for Suicidal Inpatients

NCT05486091
COMPLETED Phase 1

Cefiderocol Plasma Concentrations in Patients Receiving Renal Replacement Therapy

NCT05373615
COMPLETED Phase 4

Cefiderocol Pharmacokinetics in Adult Patients With Cystic Fibrosis

NCT05314764
COMPLETED Phase 1

Bioavailability of Tebipenem (SPR994) Crushed Tablet

NCT05296382
COMPLETED NA

Preoperative Acupuncture for Total Knee or Hip Arthroplasty

NCT06099223
COMPLETED NA

Target ADHD Executive Working Memory Study

NCT04795674
COMPLETED NA

Mobile Technology for Reducing and Preventing Adolescent Suicide

NCT04896593
COMPLETED Phase 1

Tebipenem (SPR994) Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis

NCT04919954
COMPLETED Phase 1

Imipenem-Relebactam Pharmacokinetics in Augmented Renal Clearance

NCT04147221
COMPLETED Phase 1

Omadacycline Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis

NCT04144374
COMPLETED NA

Inpatient Cognitive-Behavioral Therapy to Reduce Suicide Risk Post-Discharge

NCT04168645
COMPLETED NA

Vaginal Probiotics and Pessaries and Their Impact on the Vaginal Microenvironment

NCT04118049
COMPLETED

What is the Impact of the Presence of a Support Person on Informed Consent

NCT03966469
COMPLETED Phase 4

LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs

NCT03887650
TERMINATED Phase 4

Efficacy of Pharmacotherapy to Enhance Weight Loss Following Sleeve Gastrectomy

NCT03603080
COMPLETED NA

Enhanced Recovery After Surgery in Laparoscopic Sleeve Gastrectomy

NCT03520803
COMPLETED NA

Peritoneal Iliac Flap and Lymphocele Formation After Robotic Radical Prostatectomy

NCT03567525
COMPLETED Phase 2

Can DFN-15 Terminate Migraine With Allodynia?

NCT03472378
COMPLETED NA

Neurofeedback Training for High Risk Psychosis

NCT03447548
COMPLETED NA

An Initial Feasibility Study of Brief Cognitive Behavioral Therapy for Suicidal Inpatients

NCT03442699
COMPLETED NA

Catheter Management After Pelvic Reconstructive Surgery

NCT03071211
COMPLETED Phase 1

Tedizolid Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis

NCT02620787
COMPLETED Phase 1

Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections

NCT02620774
TERMINATED NA

Overactive Bladder Education

NCT02505607
COMPLETED NA

Phenazopyridine for Confirmation of Ureteral Patency

NCT02424149
COMPLETED NA

Timing of Pessary Care

NCT02371083
COMPLETED NA

Transcranial Magnetic Stimulation Treatment of Hoarding Disorder

NCT02236767
TERMINATED NA

Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder

NCT01815099
COMPLETED Phase 4

Decreasing Narcotics in Advanced Pelvic Surgery

NCT02110719
COMPLETED NA

Contingency Management for Hoarding Disorder

NCT04894851
COMPLETED NA

Neural Mechanisms of CBT Response in Hoarding Disorder

NCT01956344
COMPLETED Phase 4

Study to Assess Inhibition of Spore Production in Patients With C. Difficile Infections: Fidaxomicin Versus Vancomycin

NCT01818141
COMPLETED NA

Effectiveness and Neuropsychological Predictors of Guided Self-Help for Obsessive-Compulsive Disorder (OCD)

NCT01659125
COMPLETED

Locating Regions of Interest in Generalized Anxiety Disorder Using Function Magnetic Resonance Imaging (fMRI)

NCT01607710
COMPLETED NA

Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder

NCT01659736
Page 1 of 2 Next →

Phase Distribution

PhaseTrial count
Phase 1 12
Phase 2 5
Phase 3 1
Phase 4 14

Therapeutic Areas

Obesity 3
Urinary Incontinence 2
Laparoscopic Colonic Resection 1
Biomarker Change Linked to Breast Cancer 1
Relative Bioavailability 1
Attention-Deficit/Hyperactivity Disorder (Combined-subtype) 1
Cystoscopy 1
Wound Infection 1
Prolapse, Vaginal 1
Uterovaginal Prolapse 1

What is open in the Hartford Hospital pipeline

8 recruiting of 75 indexed (11% open); 56 completed (75%).

Phase mix: 15 late (III/IV) vs 17 early (I/II) (balanced across stages).

Top condition: Obesity (3 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Hartford Hospital: open-pipeline peers nationwide

Peers matched on 75 registered trials and 11% open enrollment, not the therapeutic-area sidebar.

Hartford Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 050100150200 0%10%20%30%40% Total trials Recruiting share Hartford HospitalC. R. BardECOG-ACRIN Cancer Research GroupInova Health Care ServicesIonis PharmaceuticalsUConn HealthTufts Medical CenterCAMC Health SystemBastyr University
Hartford Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Hartford Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 75 trials (± recruiting share)

Sponsors near 11% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Hartford Hospital page

75 registered trials is a research-attention snapshot, not an endorsement of Hartford Hospital or any single study.

  • 8 of Hartford Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition Hartford Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Hartford Hospital pipeline card: 75 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.